Choosing a medical device injection molder is one of the highest-stakes supplier decisions a product team makes. The right molder compresses your timeline from prototype to validated production. The wrong one — one that lacks the quality infrastructure, validation experience, or engineering depth your program demands — can delay FDA submission, force a tool transfer mid-program, or require a full revalidation at significant cost.
The questions below cut through the sales pitch. Each one targets a capability that separates a qualified medical injection molder from a commodity shop. Use them during supplier evaluations, RFQ reviews, and facility audits.
Question 1: What certifications do you hold, and are they current?
For medical device injection molding, the baseline certifications are ISO 13485:2016 and FDA Facility Registration. ISO 13485 is the internationally recognized quality management system standard for medical device manufacturing — it governs everything from document control and corrective action to supplier management and traceability. FDA registration confirms the facility is authorized to manufacture medical devices under 21 CFR Part 820.
Beyond these, ask whether the molder holds MedAccred accreditation. MedAccred is a third-party supply chain accreditation specifically for medical device manufacturers, covering plastics processing under AC8160. Fewer than 50 U.S. molders currently hold this credential. It signals that an independent auditor has verified the facility’s quality systems against standards developed by the medical device industry itself — not just that the molder has passed a generic quality audit.
PTI Engineered Plastics holds ISO 13485:2016, ISO 9001:2015, FDA Facility Registration, and MedAccred AC8160 accreditation. For programs that also touch defense or aerospace, PTI is ITAR registered.
Ask for current certificate numbers and expiration dates. A molder that can’t produce them quickly is one whose certifications may be lapsed.
Question 2: Do you have in-house IQ/OQ/PQ validation capability?
Process validation — Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) — is mandatory for most medical device injection molding programs. IQ establishes that the mold and equipment are installed correctly per specifications. OQ confirms the process operates within defined parameter limits. PQ demonstrates that the process consistently produces conforming parts under production conditions.
Some molders outsource validation or treat it as a documentation exercise. The ones worth working with have an experienced in-house validation team and a metrology lab capable of executing the dimensional, functional, and process studies required at each phase.
Ask specifically: How many tool validations do your engineers complete per year? The answer tells you whether validation is a practiced routine or an occasional scramble. PTI’s validation team completes over 100 tool validations per year using an in-house metrology lab — a volume that reflects both genuine medical program depth and the repeatability that regulated programs demand.
Also ask whether the molder can execute PPAP (Production Part Approval Process) if your program requires it, and whether they develop protocols in-house or rely on the customer to provide them.
Question 3: What are your cleanroom injection molding capabilities?
Not every medical component requires cleanroom molding, but many do — and specifying the right cleanroom class matters. ISO Class 8 (formerly Class 100,000) is the most common classification for injection molded medical device components. ISO Class 7 is required for higher-sensitivity applications.
When evaluating cleanroom capability, look beyond the classification number. Ask about square footage, whether molding presses are located inside the cleanroom or if parts are transferred from a standard production floor, what post-mold operations (assembly, packaging, labeling) can be performed in the controlled environment, and how the facility monitors and documents cleanroom compliance per ISO 14644.
PTI operates a hard-wall ISO Class 8 cleanroom exceeding 10,000 square feet, with injection molding presses, assembly, secondary operations, and packaging all located within the controlled environment. An additional 5,000 square feet of white room space supports temperature-sensitive assembly and packaging. Bioburden and ESD controls are maintained throughout all cleanroom operations.
If your device will eventually require sterile packaging or higher cleanliness classification, ask early whether the molder can scale to meet those requirements — or whether you’ll need to transfer the tool when the program matures.
Question 4: Do you practice scientific molding?
Scientific molding is a systematic, data-driven approach to developing and documenting injection molding processes. Rather than setting process parameters by feel or iteration, scientific molding uses Decoupled Molding® methodology and systematic DOE (Design of Experiments) to characterize the relationship between process inputs and part quality outputs. The result is a validated, documented process window — not a set of machine settings that only work on one press with one operator.
For medical device programs, scientific molding directly reduces validation risk. A process characterized with documented upper and lower limits for fill time, injection pressure, melt temperature, and cooling time is a process that can be re-established reliably after equipment changes, maintenance events, or tool transfers.
Ask whether the molder’s press operators are RJG-certified or formally trained in scientific molding methodology. Ask whether they use cavity pressure sensing or in-process monitoring systems. The answer tells you whether scientific molding is a marketing claim or an operational practice.
PTI uses scientific molding methodology across its production floor, including smart Arburg presses with host computer systems for process monitoring and documentation.
Question 5: Do you have an in-house toolroom?
Injection mold tooling is the most capital-intensive part of any injection molding program. Whether a molder builds tooling in-house or sends it offshore has direct implications for your lead time, change control, and program responsiveness.
A molder with an in-house toolroom can design and build molds faster, make engineering changes without the communication overhead of a separate vendor, and respond to tool repairs without waiting on a shop you’ve never audited. For medical programs in particular, tool ownership and change history documentation are QMS requirements — an in-house toolroom makes those records easier to maintain and audit.
Ask how many mold makers are on staff, what the shop’s hours of operation are, and whether the toolroom is staffed for continuous builds or operates on a limited shift schedule. A shop running single-shift toolroom operations can stretch a 10-week build into 14 or 16 weeks.
PTI’s in-house toolroom employs 35+ mold makers and has built tooling since the company’s founding in 1984. PTI builds prototype through production molds across all SPI classifications, including single and multi-cavity configurations.
Question 6: What DFM engineering services do you provide before tooling begins?
Design for Manufacturability (DFM) is a formal review of a part’s design against the realities of the injection molding process before any steel is cut. A DFM review evaluates wall thickness uniformity, draft angles, gate location, weld line placement, rib and boss geometry, and material selection — catching design issues that would otherwise surface as first-shot problems, rejects, or costly tool modifications.
The molders most worth working with don’t just produce parts — they engage with your engineering team at the design stage and flag issues early. Ask what a typical DFM review covers, how quickly one can be completed on your design data, and whether it’s included as part of the quoting process or billed separately.
PTI’s engineering team reviews customer CAD data and provides DFM recommendations before tooling begins, included as part of the quoting process at no additional cost. For programs that need deeper design involvement, PTI Design — PTI’s in-house industrial design studio — can support everything from concept through production-ready design, with manufacturing feasibility built in from the first sketch.
Question 7: What secondary operations and value-added services are available under one roof?
Medical device programs rarely involve a single molded component handed off to a separate assembler. More often, injection molded parts move through ultrasonic welding, heat staking, insert placement, pad printing, laser marking, and final assembly before they’re ready for packaging and shipment. Each handoff between facilities is a risk: a contamination point, a lead time variable, a quality event waiting to be investigated.
A single-source manufacturer — one that can take your program from molded component through finished subassembly — reduces those handoffs and gives you a single point of accountability. When a defect appears, there’s one phone call and one corrective action process, not a three-way dispute between your molder, your secondary processor, and your assembler.
Ask specifically which operations are performed on-site versus outsourced. A molder that calls themselves single-source but sends ultrasonic welding and packaging to a third party isn’t offering the same program control as one that keeps the full sequence in-house.
PTI’s value-added capabilities include sonic and spin welding, heat staking, thermal insertion, pad printing, laser marking, general assembly, and packaging — all available within PTI’s 160,000 sq ft Macomb, MI facility.
Question 8: How do you handle tool transfers, and have you done it at scale?
At some point in a program’s life, a tool transfer may be necessary — a supplier relationship changes, a facility closes, or a program outgrows a molder’s capacity. How a new molder handles a tool transfer is a direct indicator of their validation maturity and quality program depth.
A capable molder receiving a transferred tool will review all historical validation records, identify gaps in documentation, and develop appropriate IQ/OQ/PQ protocols before releasing parts to production. They’ll perform heightened inspection during the transition period and document the transfer in a way that satisfies your QMS and any FDA audit that might follow.
Ask how many tool transfers the molder has completed, what their process looks like from receipt to first validated production run, and whether they’ve handled transfers for FDA-regulated programs specifically. If the molder can’t describe a clear process — including how they handle cases where the incoming validation records are incomplete — that’s a risk worth taking seriously.
PTI’s validation team has direct experience executing tool transfers for medical device programs, including situations where historical validation documentation was partial or absent. PTI’s tool transfer process includes incoming inspection, process characterization, protocol development, and heightened lot inspection through completion of IQ/OQ/PQ.
What a Qualified Supplier Looks Like
When you work through these eight questions, a qualified medical injection molder should be able to answer each one specifically, with documented evidence. Certifications should be verifiable. Validation volume should be quantifiable. DFM capability should be demonstrable. Toolroom capacity should be auditable.
The difference between a capable medical injection molder and a commodity shop often isn’t obvious in a brochure or a price quote. It shows up when your program hits a challenge — a tight validation timeline, an out-of-spec first shot, a mid-program design change — and the molder either absorbs the problem or amplifies it.
PTI Engineered Plastics has served medical device OEMs for over 40 years from its ISO 13485:2016-certified, FDA-registered, MedAccred-accredited facility in Macomb, Michigan. PTI’s team supports programs from early-stage DFM through full IQ/OQ/PQ validation and ongoing production.
Explore PTI’s medical device injection molding capabilities →
Request a quote or DFM review →
Frequently Asked Questions
What certifications should a medical device injection molder have? At minimum, ISO 13485:2016 and FDA Facility Registration. ISO 13485 is the international quality management standard for medical device manufacturing. FDA registration is required to legally manufacture medical devices in the U.S. under 21 CFR Part 820. MedAccred accreditation (AC8160 for plastics) is an additional third-party credential that indicates a higher level of supply chain oversight — fewer than 50 U.S. molders currently hold it.
What is IQ/OQ/PQ validation and why does it matter for medical injection molding? IQ/OQ/PQ stands for Installation Qualification, Operational Qualification, and Performance Qualification. It’s a three-stage process validation protocol required for medical device manufacturing under FDA guidelines. IQ verifies that equipment is installed per specifications. OQ confirms the process operates within defined parameter limits. PQ demonstrates the process consistently produces conforming parts under actual production conditions. Without completed IQ/OQ/PQ, a manufacturing process is not considered validated for regulated medical device production.
Why does it matter whether a molder has an in-house toolroom? An in-house toolroom means your mold is built, modified, and maintained by the same team managing your production program. It eliminates the communication overhead and lead time delays that come with outsourcing tooling to a separate shop. For medical programs, it also simplifies change control documentation — all tool history stays within a single quality management system rather than spanning two vendor relationships.
What is scientific molding and why is it important for medical device programs? Scientific molding is a systematic methodology for developing and documenting injection molding processes using measurable process parameters rather than intuition or trial-and-error. It uses techniques like Decoupled Molding and Design of Experiments to characterize a validated process window. For medical device programs, scientific molding directly reduces validation risk — a well-characterized process with documented limits is easier to validate, easier to transfer, and easier to defend in an FDA audit.
What does “single-source” mean in the context of injection molding? A single-source injection molder handles more than just part production. A true single-source partner manages the full program under one roof — from tooling build and molding through secondary operations (welding, assembly, marking) and packaging. This reduces supply chain complexity, eliminates quality gaps between handoffs, and provides a single point of accountability for the entire manufacturing program.
How do I evaluate a molder’s tool transfer capability? Ask specifically how many tool transfers they’ve completed, what their process looks like from receipt through first validated production run, and how they handle gaps in incoming validation documentation. A qualified molder should have a defined process for reviewing historical validation records, performing incoming inspection, developing appropriate protocols, and executing heightened inspection through completion of IQ/OQ/PQ. Vague answers here are a meaningful risk signal.
PTI Engineered Plastics is a single-source plastic injection molding manufacturer based in Macomb, Michigan. PTI’s ISO 13485:2016-certified, FDA-registered, MedAccred-accredited facility serves medical device OEMs from prototype through validated production. Contact PTI’s engineering team or request a quote.